Natixis’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,200
Closed -$981K 1072
2024
Q1
$981K Hold
6,200
0.01% 528
2023
Q4
$972K Hold
6,200
0.01% 528
2023
Q3
$966K Buy
+6,200
New +$1.02M 0.01% 504
2022
Q4
Sell
-706
Closed -$116K 1224
2022
Q3
$116K Sell
706
-547
-44% -$92.6K ﹤0.01% 990
2022
Q2
$220K Buy
+1,253
New +$223K ﹤0.01% 1021

Other funds holding JNJ

Natixis's JNJ Position: Q2 2026 in Review

Natixis increased its Johnson & Johnson (JNJ) stake by 231% in Q2 2026, buying an estimated $115M and bringing the position to 707,790 shares worth $180M. The position accounts for 0.72% of the portfolio, ranked #21.

Natixis first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $355M in Q3 2017. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Natixis held 707,790 shares of Johnson & Johnson worth $180M as of Q2 2026.
  • Natixis bought 493,965 Johnson & Johnson shares in Q2 2026, an estimated $115M.
  • Johnson & Johnson made up 0.72% of Natixis's portfolio in Q2 2026, its #21 holding.
  • Natixis first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Natixis's Johnson & Johnson position peaked at $355M in Q3 2017.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.